1. Home
  2. CCNE vs FULC Comparison

CCNE vs FULC Comparison

Compare CCNE & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$27.27

Market Cap

818.2M

Sector

Finance

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$6.89

Market Cap

718.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCNE
FULC
Founded
1865
2015
Country
United States
United States
Employees
950
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
818.2M
718.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CCNE
FULC
Price
$27.27
$6.89
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$32.00
$16.38
AVG Volume (30 Days)
118.2K
1.2M
Earning Date
04-13-2026
04-30-2026
Dividend Yield
2.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.21
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
$11.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.32
$2.32
52 Week High
$30.84
$15.74

Technical Indicators

Market Signals
Indicator
CCNE
FULC
Relative Strength Index (RSI) 43.76 29.67
Support Level $26.25 $6.33
Resistance Level $28.32 $7.28
Average True Range (ATR) 0.82 0.47
MACD -0.07 -0.06
Stochastic Oscillator 42.44 10.38

Price Performance

Historical Comparison
CCNE
FULC

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: